Ligand Pharmaceuticals Incorporated (LGND) Monday said it intends to privately offer $400 million of senior notes due 2030.
Ligand plans to grant to the initial purchasers of the notes a 13-day option to purchase up to an additional $60 million of notes.
Ligand expects to use a portion of the net proceeds from the offering to pay the cost of the convertible note hedge transactions, which the company intends to enter into with the initial purchasers or their respective affiliates and/or other financial institutions. Additionally, Ligand expects to use up to $30 million from the proceeds to buy back its shares from certain purchasers of the notes. Remaining proceeds from the offering are expected to be used for general corporate purposes.
For comments and feedback contact: editorial@rttnews.com
Business News
May 22, 2026 14:46 ET Minutes of the latest Fed policy session was the highlight of the week along with survey data on the U.S. housing market. In Europe, survey data signaled the trends in the euro area private sector. Further, consumer price inflation data from the U.K. was in focus. In Asia, various economic indicators from China drew attention to the health of the economy.